Calendar

pharmadog

Week of Feb 16, 2026

Feb 18, 2026approval181d agoTOFACITINIB CITRATE — FDA approvaltofacitinib citrate ER

Sponsor: AJANTA PHARMA LTD. Form: TABLET. Route: ORAL

full page →tofacitinib citrate ER →fda approvals ↗

Feb 18, 2026approval181d agoTOFACITINIB CITRATE — FDA approvaltofacitinib citrate ER

Sponsor: AJANTA PHARMA LTD. Form: TABLET. Route: ORAL

full page →tofacitinib citrate ER →fda approvals ↗

Feb 18, 2026approval181d agoTOFACITINIB CITRATE — FDA approvaltofacitinib citrate ER

Sponsor: AJANTA PHARMA LTD. Form: TABLET. Route: ORAL

full page →tofacitinib citrate ER →fda approvals ↗

Feb 18, 2026approval181d agoTOFACITINIB CITRATE — FDA approvaltofacitinib citrate ER

Sponsor: AJANTA PHARMA LTD. Form: TABLET. Route: ORAL

full page →tofacitinib citrate ER →fda approvals ↗

Feb 18, 2026approval181d agoTOFACITINIB CITRATE — FDA approvaltofacitinib citrate ER

Sponsor: AJANTA PHARMA LTD. Form: TABLET. Route: ORAL

full page →tofacitinib citrate ER →fda approvals ↗

Feb 18, 2026approval181d agoARBLI (LOSARTAN POTASSIUM) — FDA approvalLOSARTAN POTASSIUM

Sponsor: SCIENTURE. Form: SUSPENSION. Route: ORAL

full page →LOSARTAN POTASSIUM →fda approvals ↗

Feb 18, 2026approval181d agoFINGOLIMOD HYDROCHLORIDE — FDA approvalEzra Ventures LLC

Sponsor: CHARTWELL RX. Form: CAPSULE. Route: ORAL

full page →fda approvals ↗

Feb 18, 2026approval181d agoFINGOLIMOD HYDROCHLORIDE — FDA approvalEzra Ventures LLC

Sponsor: CHARTWELL RX. Form: CAPSULE. Route: ORAL

full page →fda approvals ↗

Feb 18, 2026approval181d agoARIPIPRAZOLE — FDA approvalaripiprazole LA

Sponsor: AUROBINDO PHARMA. Form: TABLET, ORALLY DISINTEGRATING. Route: ORAL

full page →aripiprazole LA →fda approvals ↗

Feb 18, 2026approval181d agoEBANGA (ANSUVIMAB-ZYKL) — FDA approvalansuvimab

Sponsor: RIDGEBACK BIOTHERAPEUTICS. Form: POWDER. Route: IV (INFUSION)

full page →ansuvimab →fda approvals ↗

Feb 18, 2026approval181d agoGABAPENTIN — FDA approvalAlmatica Pharma LLC

Sponsor: IPCA LABS LTD. Form: CAPSULE. Route: ORAL

full page →fda approvals ↗

Feb 18, 2026grant181d agoBAYLOR COLLEGE OF MEDICINE — Defining the molecular mechanisms driving transovarial transmission of Acari-...Baylor College of Medicine

AI grant. $797,087. PI: Job E Lopez

full page →nih reporter ↗

Feb 18, 2026grant181d agoMCLEAN HOSPITAL — Online social networking mechanisms of suicide in adolescents

MH grant. $193,320. PI: Julianne G. Wilner

full page →nih reporter ↗

Feb 18, 2026grant181d agoOHIO STATE UNIVERSITY — PD-1H Signaling in the Regulation of the Tissue Immune Microenvironment of Lupus

AI grant. $583,909. PI: XUE HAN

full page →nih reporter ↗

Feb 18, 2026grant181d agoLA JOLLA INSTITUTE FOR IMMUNOLOGY — Deorphanizing a novel GPCR expressed by tissue resident memory cellsDawn Sea Therapeutics

AI grant. $566,875. PI: Changlu Liu

full page →nih reporter ↗

Feb 18, 2026grant181d agoCOLD SPRING HARBOR LABORATORY — CSHL 2026 Conference on Gene Expression and Signaling in the Immune System

AI grant. $10,000. PI: DAVID J. STEWART

full page →nih reporter ↗

Feb 18, 2026grant181d agoUNIVERSITY OF ILLINOIS AT URBANA-CHAMPAIGN — Endocrine Disrupting Chemicals and Female Reproductive Health

ES grant. $929,307. PI: Jodi A. Flaws

full page →nih reporter ↗

Feb 18, 2026grant181d agoUNIVERSITY OF CALIFORNIA LOS ANGELES — MAPK signaling cascade: multi-stability and dynamic information transferUniversity of California Los Angeles

AI grant. $190,804. PI: Alexander Hoffmann

full page →nih reporter ↗

Feb 18, 2026grant181d agoCEDARS-SINAI MEDICAL CENTER — Leveraging Technology to Promote Physical Activity in Patients with Prediabet...Cedars-Sinai Medical Center

DK grant. $125,250. PI: Yelba Castellon-Lopez

full page →nih reporter ↗

Feb 18, 2026grant181d agoBRANDEIS UNIVERSITY — The molecular and cellular basis of circadian rhythms in vector mosquitoes

AI grant. $779,825. PI: Paul Garrity

full page →nih reporter ↗

Feb 18, 2026grant181d agoUNIVERSITY OF ALABAMA AT BIRMINGHAM — FCRL Regulation in B Cell Tolerance and Malignancy

AI grant. $496,628. PI: RANDALL S DAVIS

full page →nih reporter ↗

Feb 18, 2026grant181d agoUNIVERSITY OF FLORIDA — Commensal bacteria-derived nanoparticles for correcting gut inflammationUniversity of Florida

AI grant. $392,142. PI: Jamal S Lewis

full page →nih reporter ↗

Feb 18, 2026grant181d agoUNIV OF MARYLAND, COLLEGE PARK — Bioimpedance Sensing Capsule for Measuring Intestinal Permeability

AI grant. $393,217. PI: Reza Ghodssi

full page →nih reporter ↗

Feb 18, 2026grant181d agoBRIGHAM AND WOMEN'S HOSPITAL — AI-guided Intestinal stem cell activation for mucosal restoration in ulcerati...Brigham and Women's Hospital

AI grant. $479,610. PI: Oren Levy

full page →nih reporter ↗

Feb 18, 2026grant181d agoGORDON RESEARCH CONFERENCES — 2026 Ligand Recognition and Molecular Gating Gordon Research Conference and G...

NS grant. $15,000. PI: Simon Scheuring

full page →nih reporter ↗

Feb 18, 2026grant181d agoUNIVERSITY OF KENTUCKY — Switches controlling bacteriophage lysis of the Lyme disease spirochete

AI grant. $420,063. PI: Brian Stevenson

full page →nih reporter ↗

Feb 18, 2026grant181d agoSTANFORD UNIVERSITY — Control of obesity by an appetite-suppressing peptideStanford University

DK grant. $782,886. PI: Katrin Jennifer Svensson

full page →nih reporter ↗

Feb 18, 2026grant181d agoUNIVERSITY OF MINNESOTA — SysTAMatic mouse model toolbox to disentangle signal transduction pathwaysUniversity of Minnesota

AI grant. $423,500. PI: Sourav Ghosh

full page →nih reporter ↗

Feb 18, 2026grant181d agoBOSTON CHILDREN'S HOSPITAL — Novel immunoregulatory mechanisms that modulate myeloid trained immunity foll...Boston Children's Hospital

AI grant. $445,000. PI: David M. Briscoe

full page →nih reporter ↗

Feb 18, 2026grant181d agoBOSTON UNIVERSITY MEDICAL CAMPUS — Vasculature and Beige Remodeling of Obese Adipose Tissue

DK grant. $817,498. PI: STEPHEN ROBERT FARMER

full page →nih reporter ↗

Feb 18, 2026grant181d agoLOUISIANA STATE UNIV HSC SHREVEPORT — The uncharacterized nuclear protein HMGXB4 in occlusive vascular diseases

HL grant. $248,679. PI: Xiangqin He

full page →nih reporter ↗

Feb 18, 2026grant181d agoRUTGERS BIOMEDICAL AND HEALTH SCIENCES — Role of a diabetes-specific circular RNA in diabetic neuropathic pain

DK grant. $802,015. PI: Steve Davidson

full page →nih reporter ↗

Feb 18, 2026grant181d agoUNIVERSITY OF KANSAS MEDICAL CENTER — Aging-Related Health and Aging Acceleration in Older Women with Criminal Lega...University of Kansas Medical Center

NR grant. $424,897. PI: Amanda Emerson

full page →nih reporter ↗

Feb 18, 2026grant181d agoGORDON RESEARCH CONFERENCES — 2026 DNA Damage, Mutation and Cancer Gordon Research Conference and Gordon Re...

CA grant. $8,000. PI: Shan Zha

full page →nih reporter ↗

Feb 18, 2026grant181d agoINDIANA UNIVERSITY INDIANAPOLIS — Signaling Mechanisms of Ultra-Stable and Glucose-Regulated Insulin AnalogsShanghai Jiao Tong University

DK grant. $811,217. PI: Alan D Cherrington

full page →nih reporter ↗

Feb 19, 2026approval180d agoELREXFIO (ELRANATAMAB) — FDA approvalelranatamab

Sponsor: PFIZER INC. Form: SOLUTION. Route: INJECTION

full page →elranatamab →fda approvals ↗

Feb 19, 2026approval180d agoDOXYCYCLINE HYCLATE — FDA approvalPolyPid Ltd.

Sponsor: AVET LIFESCIENCES. Form: INJECTABLE. Route: INJECTION

full page →fda approvals ↗

Feb 19, 2026approval180d agoBRIVARACETAM — FDA approvalBRIVARACETAM

Sponsor: MSN. Form: SOLUTION. Route: ORAL

full page →BRIVARACETAM →fda approvals ↗

Feb 19, 2026approval180d agoPOTELIGEO (MOGAMULIZUMAB-KPKC) — FDA approvalmogamulizumab

Sponsor: KYOWA KIRIN. Form: INJECTABLE. Route: INJECTION

full page →mogamulizumab →fda approvals ↗

Feb 19, 2026approval180d agoVFEND (VORICONAZOLE) — FDA approvalGreenstone LLC

Sponsor: PF PRISM CV. Form: TABLET. Route: ORAL

full page →fda approvals ↗

Feb 19, 2026approval180d agoVFEND (VORICONAZOLE) — FDA approvalGreenstone LLC

Sponsor: PF PRISM CV. Form: POWDER. Route: INTRAVENOUS

full page →fda approvals ↗

Feb 19, 2026approval180d agoVFEND (VORICONAZOLE) — FDA approvalGreenstone LLC

Sponsor: PF PRISM CV. Form: FOR SUSPENSION. Route: ORAL

full page →fda approvals ↗

Feb 19, 2026approval180d agoCALQUENCE (ACALABRUTINIB MALEATE) — FDA approvalCALQUENCE

Sponsor: ASTRAZENECA. Form: TABLET. Route: ORAL

full page →CALQUENCE →fda approvals ↗

Feb 19, 2026approval180d agoCALQUENCE (ACALABRUTINIB) — FDA approvalCALQUENCE

Sponsor: ASTRAZENECA. Form: CAPSULE. Route: ORAL

full page →CALQUENCE →fda approvals ↗

Feb 19, 2026approval180d agoVENCLEXTA (VENETOCLAX) — FDA approvalvenetoclax

Sponsor: ABBVIE. Form: TABLET. Route: ORAL

full page →venetoclax →fda approvals ↗

Feb 19, 2026grant180d agoSTANFORD UNIVERSITY — Salmonella persistence in Mesenteric Lymph NodesStanford University

AI grant. $771,210. PI: Denise M Monack

full page →nih reporter ↗

Feb 19, 2026grant180d agoGEORGIA STATE UNIVERSITY — Nanobodies as effective therapeutic agents against H5N1 influenza virus

AI grant. $434,938. PI: Lanying Du

full page →nih reporter ↗

Feb 19, 2026grant180d agoUNIVERSITY OF PITTSBURGH AT PITTSBURGH — Role of nuclear paraspeckles in regulating HSV-1 infection in neurons

AI grant. $250,682. PI: Leonardo D'Aiuto

full page →nih reporter ↗

Feb 19, 2026grant180d agoTHOMAS JEFFERSON UNIVERSITY — Trained Immunity Induced by mRNA-LNP

AI grant. $813,921. PI: Botond Z Igyarto

full page →nih reporter ↗

Feb 19, 2026grant180d agoNATIONAL JEWISH HEALTH — Prenatal programming of immune cells for tissue repair and remodeling in asthmaTissue Repair Ltd

AI grant. $776,394. PI: Magdalena Maria Gorska

full page →nih reporter ↗

← prev

page 1 of 43

Week of Feb 16, 2026